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Background: PCI of calcified compared to non-calcified coronary lesions have been associated with higher rates of adverse ischemic events. 
However, the potential association between coronary calcification and bleeding events has not been examined.
methods: Data from 6,855 pts with UA-NSTEMI or STEMI treated by PCI were pooled from 2 large-scale randomized controlled trials, ACUITY and 
HORIZONS-AMI. Angiographic assessment was done by an independent core laboratory. Patients were divided into 2 groups according to whether PCI 
lesions were vs. were not moderately/severely (M/S) calcified. Thirty-day bleeding event rates were assessed.
results: Among the total cohort, 31.9% (2,190/6,855) underwent PCI of M/S calcified lesions. At 30 days, the unadjusted rates of major CABG 
bleeding, non-CABG bleeding, and blood transfusions were significantly increased in the group with M/S calcified lesions (Table). Specifically, non-
access site bleeding, but not access-site bleeding, was associated with the severity of coronary calcification. By multivariable analysis, the PCI of 
M/S calcified lesions was a strong independent predictor of non-CABG major bleeding, CABG major bleeding, and TIMI major bleeding, with a strong 
trend for any blood product transfusion.
conclusions: in pts with acute coronary syndromes undergoing PCI, target lesion coronary calcification is strongly predictive of non-access site 
related major bleeding. Further studies are needed to elucidate the mechanisms underlying this finding. 
Table 1. Bleeding Rates Within 30-days After PCI Stratified by Severity of Target Lesion Coronary Calcification
Moderate/Severe
N=2,190
None/Mild
N=4,655
Unadjusted
p value
Adjusted Hazard Ratio 
[95% CI]
p value
Non-CABG major bleed 7.9% (171) 5.9% (273) 0.002 1.26 [1.03,1.54] 0.03
Non-CABG major bleed (excluding 
hematoma ≥ 5cm)
7.4% (159) 5.2% (239) 0.0004 1.38 [1.12,1.71] 0.002
CABG major bleed 5.5% (120) 3.2% (149) <0.0001 1.53 [1.18,1.98] 0.001
Access site related bleed 14.6% (317) 14.8% (687) 0.80 0.94 [0.82,1.08] 0.39
Retroperitoneal bleed 0.8% (15) 0.7% (34) 0.86 - -
Access site hemorrhage 0.4% (8) 0.4% (19) 0.81 - -
Hematoma ≥ 5cm at puncture site 2.0% (44) 1.8% (86) 0.62 - -
Hematoma < 5cm at puncture site 6.9% (151) 7.4% (345) 0.48 - -
Prolonged bleed at puncture site 
(>30min)
0.7% (16) 0.7% (31) 0.75 - -
Oozing at puncture site 7.3% (157) 7.1% (331) 0.90 - -
TIMI major/minor bleed 8.1% (175) 6.0% (280) 0.002 1.25 [1.02,1.53] 0.03
TIMI major bleed 2.9% (63) 1.8% (84) 0.003 1.54 [1.10,2.16] 0.01
Hgb drop ≥ 4g/dL w/o overt bleed 3.1% (66) 1.8% (82) 0.0008 1.54 [1.09,2.18] 0.01
Blood product transfusion 4.0% (86) 2.9% (136) 0.024 1.29 [0.97,1.72] 0.08
